Product from:
Preussen
744€
Only a few items left
ASS Dexcel Protect offers gastro-resistant tablets with 75 mg acetylsalicylic acid per tablet. From brand ASS, these white capsule-shaped tablets come in 100 pieces. They should be swallowed unchewed with plenty of water and kept below 25 °C. This medicine contains lactose, so always review the enclosed package leaflet carefully before use.
Zu Risiken und Nebenwirkungen lesen Sie die Packungsbeilage und fragen Sie Ihre Ärztin, Ihren Arzt oder in Ihrer Apotheke.
Similar products
More from this brand
Description
You're reading an Auto-translation.
Important notes (mandatory information)
ASS Dexcel Protect 75 mg, enteric-coated tablets. Active ingredient: acetylsalicylic acid. Areas of application: for unstable angina pectoris (heart pain due to circulatory disorders in the coronary arteries) - as part of standard therapy, for acute heart attack - as part of standard therapy, for the prevention of another heart attack after the first heart attack (for reinfarction prophylaxis), after operations or other interventions on arterial blood vessels (after arterial vascular surgery or interventional procedures, e.g. after aortocoronary vein bypass [ACVB], with percutaneous transluminal coronary angioplasty [PTCA]) and for the prevention of transient cerebral ischemia (TIA: transient ischemic attacks) and cerebral infarction after prodromal symptoms (e.g. transient paralysis in the face or arm muscles or transient loss of vision) have occurred.For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
This information was last revised in November 2014.
Source: Information from the package leaflet
Status: 06/2018
Active ingredient: acetylsalicylic acid. Areas of application: for unstable angina pectoris (heart pain due to circulatory disorders in the coronary arteries) - as part of standard therapy, for acute heart attack - as part of standard therapy, for the prevention of another heart attack after the first heart attack (for reinfarction prophylaxis), after operations or other interventions on arterial blood vessels (after arterial vascular surgery or interventional procedures, e.g. after aortocoronary vein bypass [ACVB], with percutaneous transluminal coronary angioplasty [PTCA]) and for the prevention of transient cerebral ischemia (TIA: transient ischemic attacks) and cerebral infarction after prodromal symptoms (e.g. transient paralysis in the face or arm muscles or transient loss of vision) have occurred.
Information leaflet
Download the information leafletComposition & Allergens
Composition
Wirkstoff: Acetylsalicylsäure































